Whether the high level of FGF-21 in patients with DM or atherosclerosis is supposed to provide protection against vascular injury or inflammation in atherosclerosis or is simply a new biomarker for CV diseases due to resistance to FGF-21 remains to be elucidated [8,29]. Here, FGF21 is linked to diabetes mellitus.